BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 23055019)

  • 21. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
    Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
    Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis.
    Feng H; Cheng AS; Tsang DP; Li MS; Go MY; Cheung YS; Zhao GJ; Ng SS; Lin MC; Yu J; Lai PB; To KF; Sung JJ
    J Clin Invest; 2011 Aug; 121(8):3159-75. PubMed ID: 21747169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of transcription initiation factor IIB after rat traumatic brain injury.
    Liu Z; Wang D; Shao B; Wu X; Xu J; Lu Q; Wang Y; Li C; Shen A; Wu Q
    J Mol Histol; 2011 Jun; 42(3):265-71. PubMed ID: 21544596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH.
    Qadri I; Fatima K; AbdeL-Hafiz H
    BMC Microbiol; 2011 Mar; 11():48. PubMed ID: 21375739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RPB5-mediating protein is required for the proliferation of hepatocellular carcinoma cells.
    Yang H; Gu J; Zheng Q; Li M; Lian X; Miao J; Jiang J; Wei W
    J Biol Chem; 2011 Apr; 286(13):11865-74. PubMed ID: 21310960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling.
    Hsieh A; Kim HS; Lim SO; Yu DY; Jung G
    Cancer Lett; 2011 Jan; 300(2):162-72. PubMed ID: 20971552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The linker domain of basal transcription factor TFIIB controls distinct recruitment and transcription stimulation functions.
    Wiesler SC; Weinzierl RO
    Nucleic Acids Res; 2011 Jan; 39(2):464-74. PubMed ID: 20851833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal core promoters control the equilibrium between negative cofactor 2 and preinitiation complexes in human cells.
    Albert TK; Grote K; Boeing S; Meisterernst M
    Genome Biol; 2010; 11(3):R33. PubMed ID: 20230619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of TFIIB links transcription initiation and termination.
    Wang Y; Fairley JA; Roberts SG
    Curr Biol; 2010 Mar; 20(6):548-53. PubMed ID: 20226668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of an RNA polymerase II-TFIIB complex and the transcription initiation mechanism.
    Liu X; Bushnell DA; Wang D; Calero G; Kornberg RD
    Science; 2010 Jan; 327(5962):206-9. PubMed ID: 19965383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular targeted therapies in hepatocellular carcinoma.
    Llovet JM; Bruix J
    Hepatology; 2008 Oct; 48(4):1312-27. PubMed ID: 18821591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.
    Baek HJ; Lim SC; Kitisin K; Jogunoori W; Tang Y; Marshall MB; Mishra B; Kim TH; Cho KH; Kim SS; Mishra L
    Hepatology; 2008 Oct; 48(4):1128-37. PubMed ID: 18704924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma: current management and recent advances.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TFIIB aptamers inhibit transcription by perturbing PIC formation at distinct stages.
    Sevilimedu A; Shi H; Lis JT
    Nucleic Acids Res; 2008 May; 36(9):3118-27. PubMed ID: 18403417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.
    Li X; Pan Y; Fan R; Jin H; Han S; Liu J; Wu K; Fan D
    Carcinogenesis; 2008 Aug; 29(8):1587-93. PubMed ID: 18299278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TFIIB and the regulation of transcription by RNA polymerase II.
    Deng W; Roberts SG
    Chromosoma; 2007 Oct; 116(5):417-29. PubMed ID: 17593382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.
    El-Serag HB; Rudolph KL
    Gastroenterology; 2007 Jun; 132(7):2557-76. PubMed ID: 17570226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib.
    Ueda S; Basaki Y; Yoshie M; Ogawa K; Sakisaka S; Kuwano M; Ono M
    Cancer Res; 2006 May; 66(10):5346-53. PubMed ID: 16707461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and mechanism of the RNA polymerase II transcription machinery.
    Hahn S
    Nat Struct Mol Biol; 2004 May; 11(5):394-403. PubMed ID: 15114340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP).
    Wei W; Gu JX; Zhu CQ; Sun FY; Dorjsuren D; Lin Y; Murakami S
    Cell Res; 2003 Apr; 13(2):111-20. PubMed ID: 12737519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.